Cationic porphyrins: Novel delivery vehicles for antisense oligodeoxynucleotides

Lyuba Benimetskaya, Garry B. Takle, Maria Vilenchik, Irina Lebedeva, Paul Miller, C. A. Stein

Research output: Contribution to journalArticle

Abstract

Cationic porphyrins form stable complexes with oligodeoxynucleotides. To evaluate delivery, we used a 20mer phosphorothioate oligomer (Isis 3521) targeted to the 3'-untranslated region of the PKC-α mRNA, and complexed it with porphyrin. The expression of PKC-α protein and mRNA in T24 bladder carcinoma cells was reduced by ~ 80 ± 10% at a concentration of oligomer of 3 μM, and 9 μM porphyrin. The expression of PKC-β1, -δ and -ε isoforms was unaffected by this treatment, but elimination of PKC-ζ protein and mRNA were observed. However, treatment with the porphyrin complex of Isis 3522, an oligomer which is directed at the 5' coding region of the PKC-α mRNA, was equally effective as Isis 3521 with respect to PKC-α, but did not affect PKC-ζ protein or mRNA levels. Since Isis 3521 has an 11-base region of complementarity with the PKC-ζ mRNA, wheras Isis 3522 has only a 4-base region, the effect of Isis 3521 on PKC-ζ protein and mRNA expression may be due to irrelevant cleavage. Depending upon the desired application, this new strategy may offer several advantages over other methods of antisense oligodeoxynucleotide delivery including efficiency, stability, solubility, relatively low toxicity and serum compatibility. Porphyrins may thus be a potentially useful delivery vehicle for antisense therapeutics and/or target validation.

Original languageEnglish (US)
Pages (from-to)5310-5317
Number of pages8
JournalNucleic Acids Research
Volume26
Issue number23
StatePublished - Dec 1 1998

Fingerprint

Oligodeoxyribonucleotides
Porphyrins
Messenger RNA
Proteins
3' Untranslated Regions
Solubility
Protein Isoforms
Urinary Bladder
Carcinoma
Serum

ASJC Scopus subject areas

  • Genetics

Cite this

Benimetskaya, L., Takle, G. B., Vilenchik, M., Lebedeva, I., Miller, P., & Stein, C. A. (1998). Cationic porphyrins: Novel delivery vehicles for antisense oligodeoxynucleotides. Nucleic Acids Research, 26(23), 5310-5317.

Cationic porphyrins : Novel delivery vehicles for antisense oligodeoxynucleotides. / Benimetskaya, Lyuba; Takle, Garry B.; Vilenchik, Maria; Lebedeva, Irina; Miller, Paul; Stein, C. A.

In: Nucleic Acids Research, Vol. 26, No. 23, 01.12.1998, p. 5310-5317.

Research output: Contribution to journalArticle

Benimetskaya, L, Takle, GB, Vilenchik, M, Lebedeva, I, Miller, P & Stein, CA 1998, 'Cationic porphyrins: Novel delivery vehicles for antisense oligodeoxynucleotides', Nucleic Acids Research, vol. 26, no. 23, pp. 5310-5317.
Benimetskaya L, Takle GB, Vilenchik M, Lebedeva I, Miller P, Stein CA. Cationic porphyrins: Novel delivery vehicles for antisense oligodeoxynucleotides. Nucleic Acids Research. 1998 Dec 1;26(23):5310-5317.
Benimetskaya, Lyuba ; Takle, Garry B. ; Vilenchik, Maria ; Lebedeva, Irina ; Miller, Paul ; Stein, C. A. / Cationic porphyrins : Novel delivery vehicles for antisense oligodeoxynucleotides. In: Nucleic Acids Research. 1998 ; Vol. 26, No. 23. pp. 5310-5317.
@article{f622d6592da44bdcadddf66800e41773,
title = "Cationic porphyrins: Novel delivery vehicles for antisense oligodeoxynucleotides",
abstract = "Cationic porphyrins form stable complexes with oligodeoxynucleotides. To evaluate delivery, we used a 20mer phosphorothioate oligomer (Isis 3521) targeted to the 3'-untranslated region of the PKC-α mRNA, and complexed it with porphyrin. The expression of PKC-α protein and mRNA in T24 bladder carcinoma cells was reduced by ~ 80 ± 10{\%} at a concentration of oligomer of 3 μM, and 9 μM porphyrin. The expression of PKC-β1, -δ and -ε isoforms was unaffected by this treatment, but elimination of PKC-ζ protein and mRNA were observed. However, treatment with the porphyrin complex of Isis 3522, an oligomer which is directed at the 5' coding region of the PKC-α mRNA, was equally effective as Isis 3521 with respect to PKC-α, but did not affect PKC-ζ protein or mRNA levels. Since Isis 3521 has an 11-base region of complementarity with the PKC-ζ mRNA, wheras Isis 3522 has only a 4-base region, the effect of Isis 3521 on PKC-ζ protein and mRNA expression may be due to irrelevant cleavage. Depending upon the desired application, this new strategy may offer several advantages over other methods of antisense oligodeoxynucleotide delivery including efficiency, stability, solubility, relatively low toxicity and serum compatibility. Porphyrins may thus be a potentially useful delivery vehicle for antisense therapeutics and/or target validation.",
author = "Lyuba Benimetskaya and Takle, {Garry B.} and Maria Vilenchik and Irina Lebedeva and Paul Miller and Stein, {C. A.}",
year = "1998",
month = "12",
day = "1",
language = "English (US)",
volume = "26",
pages = "5310--5317",
journal = "Nucleic Acids Research",
issn = "1362-4962",
publisher = "Oxford University Press",
number = "23",

}

TY - JOUR

T1 - Cationic porphyrins

T2 - Novel delivery vehicles for antisense oligodeoxynucleotides

AU - Benimetskaya, Lyuba

AU - Takle, Garry B.

AU - Vilenchik, Maria

AU - Lebedeva, Irina

AU - Miller, Paul

AU - Stein, C. A.

PY - 1998/12/1

Y1 - 1998/12/1

N2 - Cationic porphyrins form stable complexes with oligodeoxynucleotides. To evaluate delivery, we used a 20mer phosphorothioate oligomer (Isis 3521) targeted to the 3'-untranslated region of the PKC-α mRNA, and complexed it with porphyrin. The expression of PKC-α protein and mRNA in T24 bladder carcinoma cells was reduced by ~ 80 ± 10% at a concentration of oligomer of 3 μM, and 9 μM porphyrin. The expression of PKC-β1, -δ and -ε isoforms was unaffected by this treatment, but elimination of PKC-ζ protein and mRNA were observed. However, treatment with the porphyrin complex of Isis 3522, an oligomer which is directed at the 5' coding region of the PKC-α mRNA, was equally effective as Isis 3521 with respect to PKC-α, but did not affect PKC-ζ protein or mRNA levels. Since Isis 3521 has an 11-base region of complementarity with the PKC-ζ mRNA, wheras Isis 3522 has only a 4-base region, the effect of Isis 3521 on PKC-ζ protein and mRNA expression may be due to irrelevant cleavage. Depending upon the desired application, this new strategy may offer several advantages over other methods of antisense oligodeoxynucleotide delivery including efficiency, stability, solubility, relatively low toxicity and serum compatibility. Porphyrins may thus be a potentially useful delivery vehicle for antisense therapeutics and/or target validation.

AB - Cationic porphyrins form stable complexes with oligodeoxynucleotides. To evaluate delivery, we used a 20mer phosphorothioate oligomer (Isis 3521) targeted to the 3'-untranslated region of the PKC-α mRNA, and complexed it with porphyrin. The expression of PKC-α protein and mRNA in T24 bladder carcinoma cells was reduced by ~ 80 ± 10% at a concentration of oligomer of 3 μM, and 9 μM porphyrin. The expression of PKC-β1, -δ and -ε isoforms was unaffected by this treatment, but elimination of PKC-ζ protein and mRNA were observed. However, treatment with the porphyrin complex of Isis 3522, an oligomer which is directed at the 5' coding region of the PKC-α mRNA, was equally effective as Isis 3521 with respect to PKC-α, but did not affect PKC-ζ protein or mRNA levels. Since Isis 3521 has an 11-base region of complementarity with the PKC-ζ mRNA, wheras Isis 3522 has only a 4-base region, the effect of Isis 3521 on PKC-ζ protein and mRNA expression may be due to irrelevant cleavage. Depending upon the desired application, this new strategy may offer several advantages over other methods of antisense oligodeoxynucleotide delivery including efficiency, stability, solubility, relatively low toxicity and serum compatibility. Porphyrins may thus be a potentially useful delivery vehicle for antisense therapeutics and/or target validation.

UR - http://www.scopus.com/inward/record.url?scp=0032404159&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032404159&partnerID=8YFLogxK

M3 - Article

C2 - 9826753

AN - SCOPUS:0032404159

VL - 26

SP - 5310

EP - 5317

JO - Nucleic Acids Research

JF - Nucleic Acids Research

SN - 1362-4962

IS - 23

ER -